Oncología Traslacional
ONCTRAS
Institute of Oncology Ljubljana
Liubliana, EsloveniaPublikationen in Zusammenarbeit mit Forschern von Institute of Oncology Ljubljana (1)
2022
-
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Gynecologic Oncology, Vol. 164, Núm. 3, pp. 498-504